About 2-[[4-(5-methoxypyrimidin-2-yl)piperazin-1-yl]methyl]-4-phenyl-1,3-thiazole
2-[[4-(5-methoxypyrimidin-2-yl)piperazin-1-yl]methyl]-4-phenyl-1,3-thiazole (PubChem CID 171690826) has the molecular formula C19H21N5OS
and a molecular weight of 367.48 g/mol. Its IUPAC name is 2-[[4-(5-methoxypyrimidin-2-yl)piperazin-1-yl]methyl]-4-phenyl-1,3-thiazole.
Analyze 2-[[4-(5-methoxypyrimidin-2-yl)piperazin-1-yl]methyl]-4-phenyl-1,3-thiazole with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 2-[[4-(5-methoxypyrimidin-2-yl)piperazin-1-yl]methyl]-4-phenyl-1,3-thiazole?
The IUPAC name of 2-[[4-(5-methoxypyrimidin-2-yl)piperazin-1-yl]methyl]-4-phenyl-1,3-thiazole (CID 171690826) is 2-[[4-(5-methoxypyrimidin-2-yl)piperazin-1-yl]methyl]-4-phenyl-1,3-thiazole.
What is the SMILES notation for 2-[[4-(5-methoxypyrimidin-2-yl)piperazin-1-yl]methyl]-4-phenyl-1,3-thiazole?
The canonical SMILES for 2-[[4-(5-methoxypyrimidin-2-yl)piperazin-1-yl]methyl]-4-phenyl-1,3-thiazole is COc1cnc(N2CCN(Cc3nc(-c4ccccc4)cs3)CC2)nc1.
What is the InChIKey of 2-[[4-(5-methoxypyrimidin-2-yl)piperazin-1-yl]methyl]-4-phenyl-1,3-thiazole?
The InChIKey is PYOCVAGCLPJBKD-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H21N5OS/c1-25-16-11-20-19(21-12-16)24-9-7-23(8-10-24)13-18-22-17(14-26-18)15-5-3-2-4-6-15/h2-6,11-12,14H,7-10,13H2,1H3.
What are the key properties of 2-[[4-(5-methoxypyrimidin-2-yl)piperazin-1-yl]methyl]-4-phenyl-1,3-thiazole?
2-[[4-(5-methoxypyrimidin-2-yl)piperazin-1-yl]methyl]-4-phenyl-1,3-thiazole has a molecular weight of 367.48 g/mol, XLogP of 2.93, 5 rotatable bonds, 0 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[[4-(5-methoxypyrimidin-2-yl)piperazin-1-yl]methyl]-4-phenyl-1,3-thiazole is sourced from PubChem (CID 171690826), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).